Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

CSL Behring UK Limited
Hayworth House, Market Place, Haywards Heath, West Sussex, RH16 1DB, UK
Telephone: +44 (0)1444 447 400
Fax: +44 (0)1444 447 403
WWW: http://www.cslbehring.co.uk
Medical Information Direct Line: +44 (0)1444 447 405
Medical Information e-mail: medinfo@cslbehring.com
Customer Care direct line: +44 (0)1444 447 402
Out of Hours contact: +44 (0)1444 447 405

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 01/09/2011
PIL Helixate NexGen 2000 IU

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 20/01/2011 and displayed until 01/09/2011
Reasons for adding or updating:
  • Change to storage instructions
Updated on 14/01/2011 and displayed until 20/01/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to storage instructions
Updated on 07/01/2011 and displayed until 14/01/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to storage instructions
Updated on 16/09/2010 and displayed until 07/01/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to storage instructions
Updated on 26/04/2010 and displayed until 16/09/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
Updated on 11/09/2009 and displayed until 26/04/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 18/06/2008 and displayed until 11/09/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  octocog alfa